Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POL6326 CD34+ Mobilisation in Multiple Myeloma
2008-005046-23Phase 2Recruiting
- Sponsor
- Polyphor
- Start
- Oct 2008
- Modality
- Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of balixafortide in multiple myeloma (MM), sponsored by Polyphor. Started Oct 2008; status: recruiting.
02
Drugs
balixafortide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2008-005046-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005046-23.